Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on April 22, 2026, to announce its financial results for the first quarter ended March 31, 2026. The press release detailing these results is furnished as Exhibit 99.1 to this filing. Investors should refer to this press release for comprehensive information on the company's performance during the period. Notably, this information is furnished and not deemed "filed" for purposes of certain sections of the Securities Exchange Act, meaning it does not carry the same legal liabilities as a formally filed document under those specific provisions.
Key Highlights
- 1Boston Scientific announced its first quarter 2026 financial results on April 22, 2026.
- 2The detailed financial results are provided in a press release furnished as Exhibit 99.1.
- 3Investors should consult Exhibit 99.1 for specific performance metrics and commentary.
- 4The filing serves as an update on the company's operational and financial condition for Q1 2026.
- 5Information provided in this Item 2.02 is furnished and not deemed 'filed' under Section 18 of the Exchange Act.